Acute stroke risk prediction model based on dual-energy CTA-derived carotid plaque, perivascular adipose tissue

He Zhang1,2,3,4, Xu Xu1,2,3,5, Juan Long1,2,3

  • 1Department of Medical Imaging, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Neuroradiology
|August 7, 2025
PubMed

Insights

A new model integrating carotid plaque, perivascular adipose tissue (PVAT), and lipid biomarkers accurately predicts acute stroke risk. This tool aids in early screening and clinical intervention for stroke prevention.

Area of Science:

  • Cardiovascular Imaging and Diagnostics
  • Biomarkers and Predictive Modeling
  • Neurology and Stroke Medicine

Background:

  • Acute stroke is a leading cause of death and disability worldwide.
  • Accurate stroke risk prediction is vital for timely and effective clinical management.
  • Current prediction methods require enhancement for comprehensive risk assessment.

Purpose of the Study:

  • To develop a multidimensional model for predicting acute stroke risk.
  • To integrate carotid plaque characteristics, lumen parameters, perivascular adipose tissue (PVAT) metrics from dual-energy computed tomography angiography (DE-CTA), and serum lipid biomarkers.
  • To validate the model's predictive performance in a clinical setting.

Main Methods:

  • A retrospective dual-center study included 212 patients with DE-CTA and MRI data.
  • Quantitative parameters from DE-CTA (plaque features, lumen metrics, PVAT indices) and serum lipids were analyzed.
  • A multivariate logistic regression model was constructed using selected variables and externally validated.

Main Results:

  • The final model demonstrated robust predictive performance upon external validation.
  • Area under the ROC curve (AUC) was 0.810, with 80.8% sensitivity and 65.3% specificity.
  • The model showed good clinical applicability for acute stroke risk prediction.

Conclusions:

  • A multidimensional predictive model integrating DE-CTA imaging and serum lipid data effectively predicts acute stroke risk.
  • This quantitative tool offers a reliable method for early stroke screening.
  • The model supports timely clinical intervention strategies for stroke prevention.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
39
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
85
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
57